Clinical Trials in South Korea

Active recruiting clinical trials with sites in South Korea. Select a condition below to see detailed trial listings.

Total Trials: 195 // Recruiting: 195 // Updated: Daily

South Korea currently has 195 clinical trials with at least one registered site in the country, of which 195 are actively recruiting participants. The most studied conditions at South Korea sites are Coronary Artery Disease, Hepatocellular Carcinoma, Heart Failure, reflecting where local investigators and sponsors are concentrating enrolment.

Studies are led by sponsors including Yonsei University, Seoul National University Hospital, Samsung Medical Center. By stage, active South Korea trials break down as Phase 1 (32), Phase 2 (28), Phase 3 (11), Phase 4 (17). All figures update daily from ClinicalTrials.gov — select a condition below for full listings, eligibility and site contacts.

Top Conditions in South Korea

Coronary Artery Disease 8 Hepatocellular Carcinoma 4 Heart Failure 3 Gastric Cancer 3 Knee Osteoarthritis 3 Head and Neck Cancer 3 Parkinson Disease 3 Breast Cancer 3 Cardiovascular Diseases 3 Chronic Pain 2 Neurofibroma, Plexiform 2 Solid Tumors 2 Atrial Fibrillation 2 Gastric Adenocarcinoma 2 Stomach Neoplasms 2 Bladder Cancer 2 Epidermal Growth Factor Receptor 2 Non Small Cell Lung Cancer 2 Chronic Coronary Syndrome 2 Hepatocellular Carcinoma (HCC) 2

All Countries → All Trials →

Other Countries in This Region

🇦🇺Australia 🇯🇵Japan

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology